ATII on Nasdaq
Archimedes Tech SPAC Partners II Co.
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 |
|---|---|
| General and administrative expenses | $786.0K |
| Loss from operations | -$786.0K |
| Interest earned on cash in bank account | $8.7M |
| Total other income | $8.8M |
| Net income (loss) | $8.0M |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2024-05-31 |
|---|---|---|---|
| Cash | $1.4M | $0 | |
| Prepaid expenses | $111.4K | $0 | |
| Total current assets | $1.5M | $0 | |
| Deferred offering costs | $0 | $429.7K | |
| Prepaid insurance | $9.9K | $0 | |
| Cash held in Trust Account | $239.9M | $0 | |
| TOTAL ASSETS | $241.3M | $429.7K | |
| Accrued expenses | $61.3K | $23.0K | |
| Accrued offering costs | $75.0K | $268.4K | |
| Total current liabilities | $137.5K | $483.4K | |
| Deferred underwriting fee payable | $8.1M | $0 | |
| TOTAL LIABILITIES | $8.2M | $483.4K | |
| Ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.43 per share as of December 31, 2025 and none at December 31, 2024 | $239.9M | $0 | |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | $0 | $0 | |
| Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,590,000 and 5,750,000 shares issued and outstanding (excluding 23,000,000 and 0 shares subject to possible redemption) as of December 31, 2025 and 2024, respectively(1) | $659 | $575 | |
| Additional paid-in capital | $0 | $24.4K | |
| Accumulated deficit | -$6.7M | -$78.7K | |
| TOTAL SHAREHOLDERS DEFICIT | -$6.7M | -$53.7K | $0 |
| TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS DEFICIT | $241.3M | $429.7K | |
| Ordinary shares subject to possible redemption, redemption value per share (in dollars per share) | $10.43 | $0.00 | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in shares) | 1.0M shares | 1.0M shares | |
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 400.0M shares | 400.0M shares | |
| Common stock, shares issued (in shares) | 6.6M shares | 5.8M shares | |
| Common stock, shares outstanding (in shares) | 6.6M shares | 5.8M shares | |
| Temporary Equity, Shares Outstanding (in shares) | 23.0M shares | 0 shares | |
| Shares Subject to Forfeiture (in shares) | 750.0K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 |
|---|---|
| Net income (loss) | $8.0M |
| Interest earned on cash held in Trust Account | -$8.7M |
| Prepaid expenses | -$111.4K |
| Accrued expenses | $38.3K |
| Prepaid insurance | -$9.9K |
| Net cash used in operating activities | -$739.0K |
| Investment of cash in Trust Account | -$231.2M |
| Net cash used in investing activities | -$231.2M |
| Proceeds from sale of Units, net of underwriting discounts paid | $225.4M |
| Proceeds from sale of Private Placement Units | $8.4M |
| Repayment of due to related party | -$15.4K |
| Proceeds from promissory note - related party | $40.9K |
| Repayment of promissory noterelated party | -$290.0K |
| Payment of offering costs | -$283.7K |
| Net cash provided by financing activities | $233.3M |
| Net Change in Cash | $1.4M |
| Offering costs included in accrued offering costs | $75.0K |
| Offering costs paid by Sponsor in exchange for the issuance of Founder Shares | $0 |
| Offering costs paid through promissory note - related party | $5.4K |
| Deferred underwriting fee payable | $8.1M |
Compare Archimedes Tech SPAC Partners II Co. with another company
Recent filings
- Oct 13, 2026DEFA14A
- Sep 24, 2026DEFM14A
- Aug 14, 2026SCHEDULE 13G/A
- Aug 13, 202610-Q
- Jul 14, 20268-K
- Jun 25, 20268-K
- May 14, 202610-Q
- Apr 30, 20268-K
- Apr 30, 2026425
- Apr 23, 2026425
- Apr 22, 20268-K
- Apr 22, 2026425
- Apr 21, 2026425
- Apr 20, 20268-K
- Mar 4, 202610-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5